Our Commitment to Patients During the Stay-At-Home Order
March 24, 2020,
To Our Patients:
To protect the safety and welfare of our patients and employees, Aventiv Research has made the necessary, but difficult, decision to temporarily close our offices from March 25th through April 7th, 2020. We are rescheduling patient visits as needed. Clinical Operations are anticipated to resume on Wednesday, April 8th, 2020. Any changes to this date will be relayed to you accordingly.
The decision was made after review of all current CDC and FDA Guidance on the COVID-19 pandemic and data available. In preparation, Aventiv has reviewed upcoming patients visits that would fall during the closure and is working to see as many patients as possible within their protocol visit windows.
During the closure, if any emergent situation or safety visit is required, our staff is prepared to take all steps necessary and act accordingly. If you have any additional questions or concerns, please reach out to our Clinical Operations team below or call us at 614-501-6164.
- Meg Rood, Director of Clinical Ops – [email protected]
- Tara Friedman, Clinical Ops Manager – [email protected]
- Grazia Cannon, Investigator – [email protected]
We thank you for your continued support and look forward to resuming clinical operations very soon.
Samir Arora, M.D.
President and Medical Director